NCT04275375

Brief Summary

Spinal anaesthesia has the advantage that produced nerve block by the injection of local anaesthetic into cerebrospinal fluid (CSF). However, the greatest challenge in spinal anaesthesia is to control the spread of local anaesthetic through the CSF to provide a block which is adequate for the proposed surgery without unnecessary extensive spread, and increased risk of complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

February 12, 2020

Last Update Submit

July 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • record and compare changes in ANS function( HRV and PPGA) after spinal anesthesia in different group

    Electrocardiography and pulse photoplethysmography signals were recorded after spinal anesthesia. The spectrogram of beat-to-beat R-to-R intervals was derived by continuous wavelet transform (CWT), and the immediate power of high frequency (HFi) and low frequency (LFi) bands was extracted at 1-second intervals. The derived parameters, HF, LF, and pulse photoplethysmography amplitude, were normalized by their maximum and minimum values. Mixed-model regression and repeated-measures analysis of variance were used to explore the time-dependent effect.

    maximum for 4 hours

Study Arms (2)

hyperbaric bupivacaine

The dosage of hyperbaric bupivacaine decided by the clinical anesthesiologist. This study is an observational study.

Other: observation study about the autonomic response after spinal anesthesia

plain bupivacaine

The dosage of plain bupivacaine decided by the clinical anesthesiologist. This study is an observational study.

Other: observation study about the autonomic response after spinal anesthesia

Interventions

ECG waveforms were continuously recorded using a multichannel polygraphic system (Embla N7000, Natus, Pleasanton, CA). The data were saved at a rate of 1024 Hz directly to a memory card within the device for offline analysis of heart rate variability (HRV) and PPG. All data included in the analysis were obtained from continuous artifact-free ECG recordings for analysis of the immediate effects of spinal anesthesia.

hyperbaric bupivacaineplain bupivacaine

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The investigators conducted a prospective observational study on patients who were scheduled to undergo elective surgery and spinal anesthesia. The investigators excluded patients who had recently been treated with a sedative, beta-blocker, parasympatholytic, or opioid agent, patients who had undergone emergency surgery, those with hypovolemia and hypothermia, arrhythmia, diabetes, or impairment of renal, hepatic, coagulation, cardiac, or respiratory function

You may qualify if:

  • \. patients scheduled for operation with spinal anesthesia

You may not qualify if:

  • recently treat with a sedative, beta-blocker, parasympatholytic, or opioid agent
  • emergency surgery
  • hypovolemia and hypothermia, arrhythmia, diabetes, or impairment of renal, hepatic, coagulation, cardiac, or respiratory function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, R.o.c, 11217, Taiwan

Location

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 19, 2020

Study Start

March 1, 2019

Primary Completion

August 16, 2019

Study Completion

August 16, 2019

Last Updated

July 28, 2022

Record last verified: 2022-07

Locations